Get introduced to the
most exciting companies in
our portfolio.

SURGE Therapeutics

surgetx.com

SURGE Therapeutics is pioneering intraoperative immunotherapy to enhance cancer patient survival outcomes post-surgery. The company has developed an innovative biodegradable hydrogel that allows for the localized and prolonged release of cancer immunotherapy at the site of surgical tumor resection. This approach aims to prevent post-surgical recurrence and metastasis by effectively triggering the patient's immune system to eliminate residual cancer cells. Founded on groundbreaking research from Harvard Medical School, SURGE is positioned to transform the standard of care in cancer surgery, addressing a significant unmet medical need as over 40% of patients experience relapse within five years of surgery.